Background incidence rates of Interstitial Lung Disease

Study identification

• EU PAS number:
  EUPAS50623
• Study ID:
  50624
• Official title and acronym:
  Background incidence rates of Interstitial Lung Disease
• DARWIN EU® study:
  No
• Study countries:
  France

  Germany

  United Kingdom
• Study description:
  This was a cohort study describing incidence rates of ILD in the general population. The study population was the general population (UK), patients visiting general practices (France), and patients visiting general or specialized practices (Germany).
• Study status:
  Finalised

Research institutions and networks

Institutions

European Medicines Agency (EMA)

Study timelines

Date when funding contract was signed

Planned: 26/09/2022

Actual: 26/09/2022

Study start date

Planned: 26/09/2022

Actual: 26/09/2022

Date of final study report

Planned: 16/12/2022

Actual: 13/01/2023

Sources of funding

EMA

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable